Feldan Therapeutics
Latest round
- Series B
Last raised
- Sep 2024
Total raised
- $46M
Investors
- 10
About Feldan Therapeutics
Established in 2007 and based in Quebec, Canada, Feldan Therapeutics operates as a biotechnology company that develops peptide-based therapeutics for the treatment of various diseases, particularly those affecting skin and lungs. The firm’s proprietary technology, the Feldan Shuttle, is a peptide-based platform that enables the delivery of therapeutic compounds directly into cells, thereby targeting intracellular pathways that are typically inaccessible by conventional drugs. The company's product pipeline includes treatments for respiratory and skin diseases, with an emphasis on non-invasive therapies such as FLD-103, which is designed to treat basal cell carcinoma without surgery.
Who invested in Feldan Therapeutics
10 investors across 3 rounds
See all investors in Feldan Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Feldan Therapeutics
Who invested in Feldan Therapeutics?
Feldan Therapeutics has 10 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Feldan Therapeutics raised?
Feldan Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Feldan Therapeutics last raise money?
Feldan Therapeutics's most recent round on record is a Series B, in Sep 2024.
What does Feldan Therapeutics do?
Established in 2007 and based in Quebec, Canada, Feldan Therapeutics operates as a biotechnology company that develops peptide-based therapeutics for the treatment of various diseases, particularly those affecting skin and lungs.
Where is Feldan Therapeutics headquartered?
Feldan Therapeutics is headquartered in Quebec, Canada.
Which VCs invest in companies like Feldan Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Feldan Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Feldan Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.